SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of LENSAR, Inc. (LNSR)

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - March 24, 2025) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of LENSAR, Inc. ("LENSAR") (Nasdaq - LNSR) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Alcon. Under the terms of the transaction, Alcon will pay $14.00 per share in cash for each LENSAR share, with an additional non-tradeable contingent value right offering up to $2.75 per share in cash, conditioned on achievement of 614,000 cumulative procedures with LENSAR's products between January 1, 2026, and December 31, 2027.

The investigation concerns whether the LENSAR Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company's shareholders are receiving fair value for their shares.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/245849